Rehabilitación cardiovascular supervisada y algunos factores de riesgo en pacientes con claudicación intermitente.

Lázara M. Pérez Yánez

Resumen

Se realizó un estudio cuasiexperimental para evaluar los efectos de la rehabilitación cardiovascular supervisada sobre algunos factores de riesgo en los pacientes con claudicación intermitente que fueron rehabilitados en el HHA durante un año. Se obtuvo que la terapéutica con rehabilitación cardiovascular supervisada disminuyó, de manera significativa, el índice de masa corporal (32,8 Vs 29,6 Kg/m2), los valores de fibrinógeno (349 Vs 294 mg/L), proteína C reactiva (4,8 Vs 2,8 mg/L), glucemia (7,5 Vs 5,6 mmol/L),  hemoglobina glucosilada (6,6 Vs 5,6 %), colesterol total (6,3 Vs 4,7 mmol/l) y triglicéridos (2,6 vs 1,4 mmol/l) (p<0,001) e incrementó la hemoglobina (12,1 Vs 13,2 g/mL) y el colesterol HDL (0,8 Vs 1,4 mmol/L); (p<0,001).La rehabilitación cardiovascular supervisada mostró un efecto favorable sobre los factores de riesgo en los pacientes con claudicación intermitente.

Referencias

Aboyans V, Ricco JB, Bartelink MLEL. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the european society for vascular surgery (ESVS): : Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the european stroke organization (ESO)The task force for the diagnosis and treatment of peripheral arterial diseases of the european society of cardiology (ESC) and of the european society for vascular surgery (ESVS). Eur Heart J. 2018;39:763-816. PubMed.PMID:28886620.

Schorr EN, Treat-Jacobson D, Lindquist R. The relationship between peripheral artery disease symptomatology and ischemia. Nurs Res. 2017;66(5):378-87. PubMed:PMID:28858146.

Creager MA, Belkin M, Bluth EI. Committee to develop Clinical Data Standards for peripheral atherosclerotic vascular disease. Key data elements and definitions for peripheral atherosclerotic vascular disease: a report of the American College of Cardiology Foundation / American Heart Association Task Force on Clinical Data Standards. J Am Coll Cardiol. 2012;59:294.

Cauley JA, Kassem AM, Lane NE, Thorson S. Prevalent peripheral arterial disease and inflammatory burden. BMC Geriatr.2016;16(1):213-39.

Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509-26. PubMed:PMID:25908725.

Escobar Alfonso V, Zaldivar Garit M, Rodríguez de la Rosa G, Cabrera Cordovés JC. Factores de riesgo prevalecientes en pacientes ingresados por enfermedad cerebrovascular. Rev Cub Med. 2014;43:31-5.

Martinella Portuondo I, Vega Mengana V, García Massó D, Morlot Ruiz A, Núñez Álvarez D. Caracterización clínica de pacientes portadores de enfermedad vascular periférica complicada. Rev cub de Med Militar. 2018;47(2):1-32.

Rydén L, Grant PJ, Anker SD, Berne C, Cosentino F, Danchin N et al. Guía de práctica clínica de la ESC sobre Diabetes Mellitus, prediabetes y enfermedad cardiovascular, en colaboración con la European Society for the Study of DM. Rev Esp Cardiol. 2014;67:136:1-56.

Brief M, Schiffrin EL. Treatment of arterial remodeling in essential hypertension. Curr Hypertens Rep. 2013;15:3-9.

López Jiménez F, Pérez-Terzic C, Zeballos PC, Anchique CV, Burdiat G, González K. Consenso de RCV y Prevención Secundaria de las Sociedades Interamericana y Sudamericana de Cardiología. Rev Urug Cardiol 2013;28:189-224.

Kaplan M, Kirman S, Mohammandhassan M. Standards of medical care in DM--2017: summary of revisions. DM Care 2017;40:4-5.

Farooq U, Ray SG. Guideline for the Management of High Blood Pressure (Eighth Joint National Committee): Take-Home Messages. Med Clin North Am. 2015;99(4):733-8.

Moreno GM, Definición y clasificación de la obesidad. Rev Med Clin Los Condes. 2012;32(2):116-205.

Sharif MR, Kheirkhah D, Madani M, Kashani HH. The relationship between iron deficiency and febrile convulsion: a case-control study. Global Journal of Health Science. Global Journal of Health Science. 2015;8(2):185-189.

Davies MJ, D’Alessio DA, Fradkin J, Kernan WN, Mathieu Ch, Mingrone G et al. Management of hyperglycemia in type 2 DM. A consensus report by the American DM Association (ADA) and the European Association for the Study of DM (EASD). DM care. 2018;(41)12:2679-701.

Cefalu WT, Kaul S, Gerstein HC, Holman RR, Zinman B, Skyler JS et al. Cardiovascular outcomes trials in type 2 DM: Where do we go from here? Ref lections from a DM Care Editors’ Expert Forum DM Care 2018;41(1):14-31.

Krishna SM, Moxon JV, Golledge J. A review of the pathophysiology and potential biomarkers for peripheral artery disease. Int J Mol Sci. 2015;16(5):11294-322.

Bejarano-Lara J, Llamas-Macías FJ, Nuño-Escobar C, Calderón-Llamas MA. Biomarcadores de inflamación en pacientes con enfermedad arterial crónica de extremidades inferiores post-revascularización endovascular. Rev Mex angiol. 2018;46(2):54-60.

McDermott MM. Supervised treadmill exercise therapy for peripheral artery disease. Am Coll Cardiol [Internet]. 2017 [cited 2017 Aug 12]. Available from: https://www.acc.org/latest-in-cardiology/articles/2017/08/01/18/42/supervised-treadmill-exercise-therapy-for-peripheral-artery-disease.

Bendermacher BL, Willigendael EM, Teijink JA, Prins MH. Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication. Cochrane Database Syst Rev. 2006;(2):CD005263.

Mostaza JM, Puras E, Blasco M, Lahoz C, Samaniego ML. Utilización de tratamientos cardiovasculares preventivos y consecución de objetivos terapéuticos en pacientes con EAP. Rev Esp Cardiol. 2012;65(8):713-8.

Martínez Díaz Y, Fernández Quitana LC, Cabrera Zamora JL, Almeida Hernández Loyda. Calidad de vida en pacientes con EAP de miembros inferiores en estadios iniciales. Revista Cubana de Angiología. 2018;19(1):17-27.

Hiramoto JS, Katz R, Ix JH. Sex differences in the prevalence and clinical outcomes of subclinical peripheral artery disease in the health, aging, and body composition (Health ABC) study. Vascular. 2014;22:142–8.

Simmons KR, Sinning MA, Pearson JA, Hendrix C. Implementing a home-based exercise prescription for older patients with peripheral arterial disease and intermittent claudication: A quality improvement project. J Vasc Nurs. 2013;31(1):2-8.

Delaney CL, Muler MD, Spark JL. The impact of different supervised exercise regimen on endothelia vascular. 2015;23(6):561-9.

Harwood AE, Smith GE, Cayton T, Broadbent E, Chetter IC. A systematic review of the uptake and adherence rates to supervised exercise programs in patients with intermittent claudication. Ann Vasc Surg 2016;34:280-9.

Im HW, Baek S, Jee S, Ahn JM, Park MW, Kim WS. Barriers to Outpatient Hospital-Based Cardiac Rehabilitation in Korean Patients With Acute Coronary Syndrome. Ann Rehabil Med. 2018;42(1):154-65.

Resurrección DM, Motrico E, Rigabert A, Rubio-Valera M, Conejo-Cerón S, Pastor L et al. Barriers for Nonparticipation and Dropout of Women in Cardiac Rehabilitation Programs: A Systematic Review. Journal of women’s health. 2017;(00):15-27.

Guzmán S. YR, Estrada Z OL, Tejada PA, Crespo O. Factores relacionados con la adherencia a un programa de rehabilitación. Revista Facultad de salud. 2010;1:39-50.

Cuba. Ministerio de Salud Pública. Anuario Estadístico de Salud (2015). La Habana. Dirección Nacional de Estadísticas y Registros Médicos [Internet]; 2016 [citado 12 Ago 2017]. Disponible en: http://files.sld.cu/dne/files/2016/04/ Anuario _2015_electronico-1.pdf.

Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116:1509-26. PubMed:PMID:25908725.

Martinella Portuondo I, Vega Mengana V, García Massó D, Morlot Ruiz A, Núñez Álvarez D. Caracterización clínica de pacientes portadores de enfermedad vascular periférica complicada. Rev cub de Med Militar. 2018;47(2):1-32.

Quirós Meza G, Salazar J, Castillo J, Carrillo P. Prevalencia y factores de riesgo de enfermedad aterosclerótica sistémica. Acta Méd Costarric. 2014;56:6-11.

Mahe G, Pollak AW, Liedl DA, Cohoon KP, Mc Carter C, Rooke TW et al. Discordant diagnosis of lower extremity peripheral artery disease using american heart association post exercise guidelines. Medicine (Baltimore). 2015;94(31): e1277.

Rein P, Beer S, Saely CH, Vonbank A, Drexel H. Prevalence of impaired glucose metabolism in individuals with peripheral arterial disease. Int J Cardiol. 2010;144:243-4.

Morillas P, Cordero A, Bertomeu V, González Juanatey JR, Quiles J, Guindo J et al. Prognostic value of low ankle-brachial index in patients with hypertension and acute coronary syndromes. J Hypertens. 2009;27:341-7.

Makin A, Lip GYH, Silverman S, Beevers DG. Peripheral vascular disease and hypertension: a forgotten association?. J Hum Hypertens. 2001;15:447-54.

Loli F, Criqui M, Longoni A, Castiglioni C. Relation between risk factors and cardiovascular complications in patients with peripheral vascular disease. Results from the A.D.E.P. study. Atherosclerosis. 1996;120:25-35.

Cheng SW, Ting AC, Lau H, Wong J. Epidemiology of atherosclerotic peripheral arterial occlusive disease in Hong Kong. World J Surg. 1999;23:202-6.

Singh S, Sethi A, Singh M, Khosla K, Grewal N, Khosla S. Simultaneously measured inter-arm and inter-leg systolic blood pressure differences and cardiovascular risk stratification: a systemic review and meta-analysis. J Am Soc Hypertens. 2015;9:640–50.

Marie D, Gerhard-Herman MD, Gornik HL, Barrett C. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol 2017;69:1465-508.

Alahdab F, Wang AT, Elraiyah TA. A systematic review for the screening for peripheral arterial disease in asymptomatic patients. J Vasc Surg. 2015;61(3) (suppl):42S-53S.

Marcus BH, Albrecht AE, King TK, Parisi AF, Pinto BM, Roberts M et al. The efficacy of exercise as an aid for smoking cessation in women: a randomized controlled trial. Arch Intern Med. 1999;159:1229-34.

Reiner Z. Resistance and intolerance to statins. Nutr Metab Cardiovasc Dis. 2014;24:1057–66.

Ix JH. Association of body mass index with peripheral arterial disease in older adults: the cardiovascular health study. Am. J. Epidemiol. 2011;174:1036–43.

BoseVski M, BoseVska G, StojanoVska L. Influence of fibrinogen and C-RP on progression of peripheral arterial disease in type 2 DM: a preliminary report. Cardiovascular Diabetology, BioMed Central 2013;12(29):35-7.

Stone PA, Yacoub M. Inflammatory biomarkers in peripheral arterial disease. Semin Vasc Surg. 2014;27:148–51.

Leon AS, Sanchez O. Meta-analysis of the effects of aerobic exercise training on blood lipids. Circulation. 2001;104:II414-15.

Pérez Yánez LM, García Hernández RA. Comportamiento de los factores de riesgo coronario en los pacientes rehabilitados en el Hospital Hermanos Ameijeiras. Rev Cubana Cardiol Cir Cardiovasc. 2012;18:199-203.

Pérez Yánez LM, García Hernández RA. Factores de riesgo coronarios en pacientes con prótesis aórtica durante rehabilitación cardiaca. Rev Cubana Medicina. 2013;52:99-108.

Thompson PD, Crouse SF, Goodpaster B, Kelley D, Moyna N, Pescatello L et al. The acute versus the chronic response to exercise. Med Sci Sports Exerc. 2001;33:S438-45.

Pérez Yánez LM, Gutiérrez López A. Rehabilitación cardiovascular en los pacientes con claudicación intermitente. CorSalud. 2017;9:106-13.

Popplewell MA., Bradbury AW. Why do health systems not found supervised exercise programmes for intermittent claudication?. Eur J Vasc Endovasc Surg. 2014;48:608–10.

Quirós Meza G, Salazar J, Castillo J, Miranda P. Prevalencia de Enfermedad arterial periférica, enfermedad carotidea aterosclerótica y factores de riesgo asociados en una población adulta mayor cantón de Garabito, Puntarenas. Neuroeje. 2013;25:20-35.

Zurita-Cruz JN, Márquez-González H, Miranda-Novales G, Villasís-Keever MA. Estudios experimentales: diseños de investigación para la evaluación de intervenciones en la clínica. Rev Alerg Mex. 2018;65(2):178-86.

Enlaces refback

  • No hay ningún enlace refback.


Licencia de Creative Commons
Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.